Genflow Biosciences plc (LON:GENF – Get Free Report) traded down 9.1% during trading on Thursday . The company traded as low as GBX 1.99 and last traded at GBX 2. Approximately 2,734,865 shares changed hands during mid-day trading, an increase of 21% from the average session volume of 2,261,087 shares. The stock had previously closed at GBX 2.20.
Genflow Biosciences Price Performance
The stock has a market cap of £11.33 million, a price-to-earnings ratio of -6.02 and a beta of 2.31. The firm has a 50 day simple moving average of GBX 2.25 and a two-hundred day simple moving average of GBX 2.04.
Genflow Biosciences (LON:GENF – Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported GBX (0.33) earnings per share (EPS) for the quarter. Genflow Biosciences had a return on equity of 377.33% and a net margin of 840.76%.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Further Reading
- Five stocks we like better than Genflow Biosciences
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
